Global Antibody Drug Conjugate Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Antibody Drug Conjugate Industry Forecast” looks at past sales and reviews total world Antibody Drug Conjugate sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody Drug Conjugate sales for 2023 through 2029. With Antibody Drug Conjugate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drug Conjugate industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drug Conjugate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drug Conjugate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antibody Drug Conjugate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drug Conjugate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drug Conjugate.
The global Antibody Drug Conjugate market size is projected to grow from US$ 1660 million in 2022 to US$ 2769.7 million in 2029; it is expected to grow at a CAGR of 2769.7 from 2023 to 2029.
United States market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibody Drug Conjugate players cover Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, Pfizer, Celldex Therapeutics, Millennium Pharmaceuticals, Bayer HealthCare and Mersana Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Antibody Drug Conjugate market?
What factors are driving Antibody Drug Conjugate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody Drug Conjugate market opportunities vary by end market size?
How does Antibody Drug Conjugate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Antibody Drug Conjugate Industry Forecast” looks at past sales and reviews total world Antibody Drug Conjugate sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody Drug Conjugate sales for 2023 through 2029. With Antibody Drug Conjugate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drug Conjugate industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drug Conjugate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drug Conjugate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antibody Drug Conjugate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drug Conjugate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drug Conjugate.
The global Antibody Drug Conjugate market size is projected to grow from US$ 1660 million in 2022 to US$ 2769.7 million in 2029; it is expected to grow at a CAGR of 2769.7 from 2023 to 2029.
United States market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibody Drug Conjugate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibody Drug Conjugate players cover Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, Pfizer, Celldex Therapeutics, Millennium Pharmaceuticals, Bayer HealthCare and Mersana Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Adcetris
- Kadcyl
- Other
- Hospital
- Pharmaceutical Company
- Research Institutions
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seattle Genetics/Takeda
- Roche
- ImmunoGen
- Immunomedics
- Pfizer
- Celldex Therapeutics
- Millennium Pharmaceuticals
- Bayer HealthCare
- Mersana Therapeutics
- Heidelberg Pharma
- Oxford BioTherapeutics
- Takeda Pharmaceutical Company Limited
What is the 10-year outlook for the global Antibody Drug Conjugate market?
What factors are driving Antibody Drug Conjugate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody Drug Conjugate market opportunities vary by end market size?
How does Antibody Drug Conjugate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antibody Drug Conjugate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antibody Drug Conjugate by Country/Region, 2018, 2022 & 2029
2.2 Antibody Drug Conjugate Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyl
2.2.3 Other
2.3 Antibody Drug Conjugate Sales by Type
2.3.1 Global Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
2.3.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antibody Drug Conjugate Sale Price by Type (2018-2023)
2.4 Antibody Drug Conjugate Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Company
2.4.3 Research Institutions
2.5 Antibody Drug Conjugate Sales by Application
2.5.1 Global Antibody Drug Conjugate Sale Market Share by Application (2018-2023)
2.5.2 Global Antibody Drug Conjugate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antibody Drug Conjugate Sale Price by Application (2018-2023)
3 GLOBAL ANTIBODY DRUG CONJUGATE BY COMPANY
3.1 Global Antibody Drug Conjugate Breakdown Data by Company
3.1.1 Global Antibody Drug Conjugate Annual Sales by Company (2018-2023)
3.1.2 Global Antibody Drug Conjugate Sales Market Share by Company (2018-2023)
3.2 Global Antibody Drug Conjugate Annual Revenue by Company (2018-2023)
3.2.1 Global Antibody Drug Conjugate Revenue by Company (2018-2023)
3.2.2 Global Antibody Drug Conjugate Revenue Market Share by Company (2018-2023)
3.3 Global Antibody Drug Conjugate Sale Price by Company
3.4 Key Manufacturers Antibody Drug Conjugate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Drug Conjugate Product Location Distribution
3.4.2 Players Antibody Drug Conjugate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIBODY DRUG CONJUGATE BY GEOGRAPHIC REGION
4.1 World Historic Antibody Drug Conjugate Market Size by Geographic Region (2018-2023)
4.1.1 Global Antibody Drug Conjugate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antibody Drug Conjugate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antibody Drug Conjugate Market Size by Country/Region (2018-2023)
4.2.1 Global Antibody Drug Conjugate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antibody Drug Conjugate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antibody Drug Conjugate Sales Growth
4.4 APAC Antibody Drug Conjugate Sales Growth
4.5 Europe Antibody Drug Conjugate Sales Growth
4.6 Middle East & Africa Antibody Drug Conjugate Sales Growth
5 AMERICAS
5.1 Americas Antibody Drug Conjugate Sales by Country
5.1.1 Americas Antibody Drug Conjugate Sales by Country (2018-2023)
5.1.2 Americas Antibody Drug Conjugate Revenue by Country (2018-2023)
5.2 Americas Antibody Drug Conjugate Sales by Type
5.3 Americas Antibody Drug Conjugate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugate Sales by Region
6.1.1 APAC Antibody Drug Conjugate Sales by Region (2018-2023)
6.1.2 APAC Antibody Drug Conjugate Revenue by Region (2018-2023)
6.2 APAC Antibody Drug Conjugate Sales by Type
6.3 APAC Antibody Drug Conjugate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody Drug Conjugate by Country
7.1.1 Europe Antibody Drug Conjugate Sales by Country (2018-2023)
7.1.2 Europe Antibody Drug Conjugate Revenue by Country (2018-2023)
7.2 Europe Antibody Drug Conjugate Sales by Type
7.3 Europe Antibody Drug Conjugate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drug Conjugate by Country
8.1.1 Middle East & Africa Antibody Drug Conjugate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antibody Drug Conjugate Revenue by Country (2018-2023)
8.2 Middle East & Africa Antibody Drug Conjugate Sales by Type
8.3 Middle East & Africa Antibody Drug Conjugate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugate
10.3 Manufacturing Process Analysis of Antibody Drug Conjugate
10.4 Industry Chain Structure of Antibody Drug Conjugate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Drug Conjugate Distributors
11.3 Antibody Drug Conjugate Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY DRUG CONJUGATE BY GEOGRAPHIC REGION
12.1 Global Antibody Drug Conjugate Market Size Forecast by Region
12.1.1 Global Antibody Drug Conjugate Forecast by Region (2024-2029)
12.1.2 Global Antibody Drug Conjugate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibody Drug Conjugate Forecast by Type
12.7 Global Antibody Drug Conjugate Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Seattle Genetics/Takeda
13.1.1 Seattle Genetics/Takeda Company Information
13.1.2 Seattle Genetics/Takeda Antibody Drug Conjugate Product Portfolios and Specifications
13.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Seattle Genetics/Takeda Main Business Overview
13.1.5 Seattle Genetics/Takeda Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Antibody Drug Conjugate Product Portfolios and Specifications
13.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 ImmunoGen
13.3.1 ImmunoGen Company Information
13.3.2 ImmunoGen Antibody Drug Conjugate Product Portfolios and Specifications
13.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ImmunoGen Main Business Overview
13.3.5 ImmunoGen Latest Developments
13.4 Immunomedics
13.4.1 Immunomedics Company Information
13.4.2 Immunomedics Antibody Drug Conjugate Product Portfolios and Specifications
13.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Immunomedics Main Business Overview
13.4.5 Immunomedics Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Antibody Drug Conjugate Product Portfolios and Specifications
13.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Celldex Therapeutics
13.6.1 Celldex Therapeutics Company Information
13.6.2 Celldex Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Celldex Therapeutics Main Business Overview
13.6.5 Celldex Therapeutics Latest Developments
13.7 Millennium Pharmaceuticals
13.7.1 Millennium Pharmaceuticals Company Information
13.7.2 Millennium Pharmaceuticals Antibody Drug Conjugate Product Portfolios and Specifications
13.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Millennium Pharmaceuticals Main Business Overview
13.7.5 Millennium Pharmaceuticals Latest Developments
13.8 Bayer HealthCare
13.8.1 Bayer HealthCare Company Information
13.8.2 Bayer HealthCare Antibody Drug Conjugate Product Portfolios and Specifications
13.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer HealthCare Main Business Overview
13.8.5 Bayer HealthCare Latest Developments
13.9 Mersana Therapeutics
13.9.1 Mersana Therapeutics Company Information
13.9.2 Mersana Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mersana Therapeutics Main Business Overview
13.9.5 Mersana Therapeutics Latest Developments
13.10 Heidelberg Pharma
13.10.1 Heidelberg Pharma Company Information
13.10.2 Heidelberg Pharma Antibody Drug Conjugate Product Portfolios and Specifications
13.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Heidelberg Pharma Main Business Overview
13.10.5 Heidelberg Pharma Latest Developments
13.11 Oxford BioTherapeutics
13.11.1 Oxford BioTherapeutics Company Information
13.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Oxford BioTherapeutics Main Business Overview
13.11.5 Oxford BioTherapeutics Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antibody Drug Conjugate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antibody Drug Conjugate by Country/Region, 2018, 2022 & 2029
2.2 Antibody Drug Conjugate Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyl
2.2.3 Other
2.3 Antibody Drug Conjugate Sales by Type
2.3.1 Global Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
2.3.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antibody Drug Conjugate Sale Price by Type (2018-2023)
2.4 Antibody Drug Conjugate Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Company
2.4.3 Research Institutions
2.5 Antibody Drug Conjugate Sales by Application
2.5.1 Global Antibody Drug Conjugate Sale Market Share by Application (2018-2023)
2.5.2 Global Antibody Drug Conjugate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antibody Drug Conjugate Sale Price by Application (2018-2023)
3 GLOBAL ANTIBODY DRUG CONJUGATE BY COMPANY
3.1 Global Antibody Drug Conjugate Breakdown Data by Company
3.1.1 Global Antibody Drug Conjugate Annual Sales by Company (2018-2023)
3.1.2 Global Antibody Drug Conjugate Sales Market Share by Company (2018-2023)
3.2 Global Antibody Drug Conjugate Annual Revenue by Company (2018-2023)
3.2.1 Global Antibody Drug Conjugate Revenue by Company (2018-2023)
3.2.2 Global Antibody Drug Conjugate Revenue Market Share by Company (2018-2023)
3.3 Global Antibody Drug Conjugate Sale Price by Company
3.4 Key Manufacturers Antibody Drug Conjugate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Drug Conjugate Product Location Distribution
3.4.2 Players Antibody Drug Conjugate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTIBODY DRUG CONJUGATE BY GEOGRAPHIC REGION
4.1 World Historic Antibody Drug Conjugate Market Size by Geographic Region (2018-2023)
4.1.1 Global Antibody Drug Conjugate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antibody Drug Conjugate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antibody Drug Conjugate Market Size by Country/Region (2018-2023)
4.2.1 Global Antibody Drug Conjugate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antibody Drug Conjugate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antibody Drug Conjugate Sales Growth
4.4 APAC Antibody Drug Conjugate Sales Growth
4.5 Europe Antibody Drug Conjugate Sales Growth
4.6 Middle East & Africa Antibody Drug Conjugate Sales Growth
5 AMERICAS
5.1 Americas Antibody Drug Conjugate Sales by Country
5.1.1 Americas Antibody Drug Conjugate Sales by Country (2018-2023)
5.1.2 Americas Antibody Drug Conjugate Revenue by Country (2018-2023)
5.2 Americas Antibody Drug Conjugate Sales by Type
5.3 Americas Antibody Drug Conjugate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugate Sales by Region
6.1.1 APAC Antibody Drug Conjugate Sales by Region (2018-2023)
6.1.2 APAC Antibody Drug Conjugate Revenue by Region (2018-2023)
6.2 APAC Antibody Drug Conjugate Sales by Type
6.3 APAC Antibody Drug Conjugate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody Drug Conjugate by Country
7.1.1 Europe Antibody Drug Conjugate Sales by Country (2018-2023)
7.1.2 Europe Antibody Drug Conjugate Revenue by Country (2018-2023)
7.2 Europe Antibody Drug Conjugate Sales by Type
7.3 Europe Antibody Drug Conjugate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drug Conjugate by Country
8.1.1 Middle East & Africa Antibody Drug Conjugate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antibody Drug Conjugate Revenue by Country (2018-2023)
8.2 Middle East & Africa Antibody Drug Conjugate Sales by Type
8.3 Middle East & Africa Antibody Drug Conjugate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugate
10.3 Manufacturing Process Analysis of Antibody Drug Conjugate
10.4 Industry Chain Structure of Antibody Drug Conjugate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Drug Conjugate Distributors
11.3 Antibody Drug Conjugate Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY DRUG CONJUGATE BY GEOGRAPHIC REGION
12.1 Global Antibody Drug Conjugate Market Size Forecast by Region
12.1.1 Global Antibody Drug Conjugate Forecast by Region (2024-2029)
12.1.2 Global Antibody Drug Conjugate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibody Drug Conjugate Forecast by Type
12.7 Global Antibody Drug Conjugate Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Seattle Genetics/Takeda
13.1.1 Seattle Genetics/Takeda Company Information
13.1.2 Seattle Genetics/Takeda Antibody Drug Conjugate Product Portfolios and Specifications
13.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Seattle Genetics/Takeda Main Business Overview
13.1.5 Seattle Genetics/Takeda Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Antibody Drug Conjugate Product Portfolios and Specifications
13.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 ImmunoGen
13.3.1 ImmunoGen Company Information
13.3.2 ImmunoGen Antibody Drug Conjugate Product Portfolios and Specifications
13.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ImmunoGen Main Business Overview
13.3.5 ImmunoGen Latest Developments
13.4 Immunomedics
13.4.1 Immunomedics Company Information
13.4.2 Immunomedics Antibody Drug Conjugate Product Portfolios and Specifications
13.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Immunomedics Main Business Overview
13.4.5 Immunomedics Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Antibody Drug Conjugate Product Portfolios and Specifications
13.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Celldex Therapeutics
13.6.1 Celldex Therapeutics Company Information
13.6.2 Celldex Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Celldex Therapeutics Main Business Overview
13.6.5 Celldex Therapeutics Latest Developments
13.7 Millennium Pharmaceuticals
13.7.1 Millennium Pharmaceuticals Company Information
13.7.2 Millennium Pharmaceuticals Antibody Drug Conjugate Product Portfolios and Specifications
13.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Millennium Pharmaceuticals Main Business Overview
13.7.5 Millennium Pharmaceuticals Latest Developments
13.8 Bayer HealthCare
13.8.1 Bayer HealthCare Company Information
13.8.2 Bayer HealthCare Antibody Drug Conjugate Product Portfolios and Specifications
13.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer HealthCare Main Business Overview
13.8.5 Bayer HealthCare Latest Developments
13.9 Mersana Therapeutics
13.9.1 Mersana Therapeutics Company Information
13.9.2 Mersana Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mersana Therapeutics Main Business Overview
13.9.5 Mersana Therapeutics Latest Developments
13.10 Heidelberg Pharma
13.10.1 Heidelberg Pharma Company Information
13.10.2 Heidelberg Pharma Antibody Drug Conjugate Product Portfolios and Specifications
13.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Heidelberg Pharma Main Business Overview
13.10.5 Heidelberg Pharma Latest Developments
13.11 Oxford BioTherapeutics
13.11.1 Oxford BioTherapeutics Company Information
13.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Product Portfolios and Specifications
13.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Oxford BioTherapeutics Main Business Overview
13.11.5 Oxford BioTherapeutics Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antibody Drug Conjugate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antibody Drug Conjugate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adcetris
Table 4. Major Players of Kadcyl
Table 5. Major Players of Other
Table 6. Global Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 7. Global Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Table 8. Global Antibody Drug Conjugate Revenue by Type (2018-2023) & ($ million)
Table 9. Global Antibody Drug Conjugate Revenue Market Share by Type (2018-2023)
Table 10. Global Antibody Drug Conjugate Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 12. Global Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Table 13. Global Antibody Drug Conjugate Revenue by Application (2018-2023)
Table 14. Global Antibody Drug Conjugate Revenue Market Share by Application (2018-2023)
Table 15. Global Antibody Drug Conjugate Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Antibody Drug Conjugate Sales by Company (2018-2023) & (K Units)
Table 17. Global Antibody Drug Conjugate Sales Market Share by Company (2018-2023)
Table 18. Global Antibody Drug Conjugate Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Antibody Drug Conjugate Revenue Market Share by Company (2018-2023)
Table 20. Global Antibody Drug Conjugate Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Antibody Drug Conjugate Producing Area Distribution and Sales Area
Table 22. Players Antibody Drug Conjugate Products Offered
Table 23. Antibody Drug Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antibody Drug Conjugate Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Antibody Drug Conjugate Sales Market Share Geographic Region (2018-2023)
Table 28. Global Antibody Drug Conjugate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Antibody Drug Conjugate Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Antibody Drug Conjugate Sales Market Share by Country/Region (2018-2023)
Table 32. Global Antibody Drug Conjugate Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Antibody Drug Conjugate Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 35. Americas Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 36. Americas Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 38. Americas Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 39. Americas Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 40. APAC Antibody Drug Conjugate Sales by Region (2018-2023) & (K Units)
Table 41. APAC Antibody Drug Conjugate Sales Market Share by Region (2018-2023)
Table 42. APAC Antibody Drug Conjugate Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Antibody Drug Conjugate Revenue Market Share by Region (2018-2023)
Table 44. APAC Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 45. APAC Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 46. Europe Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 47. Europe Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 48. Europe Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 50. Europe Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 51. Europe Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate
Table 59. Key Market Challenges & Risks of Antibody Drug Conjugate
Table 60. Key Industry Trends of Antibody Drug Conjugate
Table 61. Antibody Drug Conjugate Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Antibody Drug Conjugate Distributors List
Table 64. Antibody Drug Conjugate Customer List
Table 65. Global Antibody Drug Conjugate Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Antibody Drug Conjugate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Antibody Drug Conjugate Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Antibody Drug Conjugate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Antibody Drug Conjugate Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Antibody Drug Conjugate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Antibody Drug Conjugate Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Antibody Drug Conjugate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Seattle Genetics/Takeda Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 80. Seattle Genetics/Takeda Antibody Drug Conjugate Product Portfolios and Specifications
Table 81. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Seattle Genetics/Takeda Main Business
Table 83. Seattle Genetics/Takeda Latest Developments
Table 84. Roche Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Antibody Drug Conjugate Product Portfolios and Specifications
Table 86. Roche Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. ImmunoGen Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 90. ImmunoGen Antibody Drug Conjugate Product Portfolios and Specifications
Table 91. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. ImmunoGen Main Business
Table 93. ImmunoGen Latest Developments
Table 94. Immunomedics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 95. Immunomedics Antibody Drug Conjugate Product Portfolios and Specifications
Table 96. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Immunomedics Main Business
Table 98. Immunomedics Latest Developments
Table 99. Pfizer Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Antibody Drug Conjugate Product Portfolios and Specifications
Table 101. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Celldex Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 105. Celldex Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 106. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Celldex Therapeutics Main Business
Table 108. Celldex Therapeutics Latest Developments
Table 109. Millennium Pharmaceuticals Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 110. Millennium Pharmaceuticals Antibody Drug Conjugate Product Portfolios and Specifications
Table 111. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Millennium Pharmaceuticals Main Business
Table 113. Millennium Pharmaceuticals Latest Developments
Table 114. Bayer HealthCare Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer HealthCare Antibody Drug Conjugate Product Portfolios and Specifications
Table 116. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Bayer HealthCare Main Business
Table 118. Bayer HealthCare Latest Developments
Table 119. Mersana Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 120. Mersana Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 121. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Mersana Therapeutics Main Business
Table 123. Mersana Therapeutics Latest Developments
Table 124. Heidelberg Pharma Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 125. Heidelberg Pharma Antibody Drug Conjugate Product Portfolios and Specifications
Table 126. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Heidelberg Pharma Main Business
Table 128. Heidelberg Pharma Latest Developments
Table 129. Oxford BioTherapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 130. Oxford BioTherapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 131. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Oxford BioTherapeutics Main Business
Table 133. Oxford BioTherapeutics Latest Developments
Table 134. Takeda Pharmaceutical Company Limited Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 135. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Portfolios and Specifications
Table 136. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Takeda Pharmaceutical Company Limited Main Business
Table 138. Takeda Pharmaceutical Company Limited Latest Developments
Table 1. Antibody Drug Conjugate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antibody Drug Conjugate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adcetris
Table 4. Major Players of Kadcyl
Table 5. Major Players of Other
Table 6. Global Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 7. Global Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Table 8. Global Antibody Drug Conjugate Revenue by Type (2018-2023) & ($ million)
Table 9. Global Antibody Drug Conjugate Revenue Market Share by Type (2018-2023)
Table 10. Global Antibody Drug Conjugate Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 12. Global Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Table 13. Global Antibody Drug Conjugate Revenue by Application (2018-2023)
Table 14. Global Antibody Drug Conjugate Revenue Market Share by Application (2018-2023)
Table 15. Global Antibody Drug Conjugate Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Antibody Drug Conjugate Sales by Company (2018-2023) & (K Units)
Table 17. Global Antibody Drug Conjugate Sales Market Share by Company (2018-2023)
Table 18. Global Antibody Drug Conjugate Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Antibody Drug Conjugate Revenue Market Share by Company (2018-2023)
Table 20. Global Antibody Drug Conjugate Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Antibody Drug Conjugate Producing Area Distribution and Sales Area
Table 22. Players Antibody Drug Conjugate Products Offered
Table 23. Antibody Drug Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antibody Drug Conjugate Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Antibody Drug Conjugate Sales Market Share Geographic Region (2018-2023)
Table 28. Global Antibody Drug Conjugate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Antibody Drug Conjugate Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Antibody Drug Conjugate Sales Market Share by Country/Region (2018-2023)
Table 32. Global Antibody Drug Conjugate Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Antibody Drug Conjugate Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 35. Americas Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 36. Americas Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 38. Americas Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 39. Americas Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 40. APAC Antibody Drug Conjugate Sales by Region (2018-2023) & (K Units)
Table 41. APAC Antibody Drug Conjugate Sales Market Share by Region (2018-2023)
Table 42. APAC Antibody Drug Conjugate Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Antibody Drug Conjugate Revenue Market Share by Region (2018-2023)
Table 44. APAC Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 45. APAC Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 46. Europe Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 47. Europe Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 48. Europe Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 50. Europe Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 51. Europe Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Antibody Drug Conjugate Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Antibody Drug Conjugate Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Antibody Drug Conjugate Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Antibody Drug Conjugate Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate
Table 59. Key Market Challenges & Risks of Antibody Drug Conjugate
Table 60. Key Industry Trends of Antibody Drug Conjugate
Table 61. Antibody Drug Conjugate Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Antibody Drug Conjugate Distributors List
Table 64. Antibody Drug Conjugate Customer List
Table 65. Global Antibody Drug Conjugate Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Antibody Drug Conjugate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Antibody Drug Conjugate Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Antibody Drug Conjugate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Antibody Drug Conjugate Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Antibody Drug Conjugate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Antibody Drug Conjugate Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Antibody Drug Conjugate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Antibody Drug Conjugate Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Antibody Drug Conjugate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Seattle Genetics/Takeda Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 80. Seattle Genetics/Takeda Antibody Drug Conjugate Product Portfolios and Specifications
Table 81. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Seattle Genetics/Takeda Main Business
Table 83. Seattle Genetics/Takeda Latest Developments
Table 84. Roche Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Antibody Drug Conjugate Product Portfolios and Specifications
Table 86. Roche Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. ImmunoGen Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 90. ImmunoGen Antibody Drug Conjugate Product Portfolios and Specifications
Table 91. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. ImmunoGen Main Business
Table 93. ImmunoGen Latest Developments
Table 94. Immunomedics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 95. Immunomedics Antibody Drug Conjugate Product Portfolios and Specifications
Table 96. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Immunomedics Main Business
Table 98. Immunomedics Latest Developments
Table 99. Pfizer Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Antibody Drug Conjugate Product Portfolios and Specifications
Table 101. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Celldex Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 105. Celldex Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 106. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Celldex Therapeutics Main Business
Table 108. Celldex Therapeutics Latest Developments
Table 109. Millennium Pharmaceuticals Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 110. Millennium Pharmaceuticals Antibody Drug Conjugate Product Portfolios and Specifications
Table 111. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Millennium Pharmaceuticals Main Business
Table 113. Millennium Pharmaceuticals Latest Developments
Table 114. Bayer HealthCare Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer HealthCare Antibody Drug Conjugate Product Portfolios and Specifications
Table 116. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Bayer HealthCare Main Business
Table 118. Bayer HealthCare Latest Developments
Table 119. Mersana Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 120. Mersana Therapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 121. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Mersana Therapeutics Main Business
Table 123. Mersana Therapeutics Latest Developments
Table 124. Heidelberg Pharma Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 125. Heidelberg Pharma Antibody Drug Conjugate Product Portfolios and Specifications
Table 126. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Heidelberg Pharma Main Business
Table 128. Heidelberg Pharma Latest Developments
Table 129. Oxford BioTherapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 130. Oxford BioTherapeutics Antibody Drug Conjugate Product Portfolios and Specifications
Table 131. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Oxford BioTherapeutics Main Business
Table 133. Oxford BioTherapeutics Latest Developments
Table 134. Takeda Pharmaceutical Company Limited Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors
Table 135. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Portfolios and Specifications
Table 136. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Takeda Pharmaceutical Company Limited Main Business
Table 138. Takeda Pharmaceutical Company Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antibody Drug Conjugate
Figure 2. Antibody Drug Conjugate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Drug Conjugate Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antibody Drug Conjugate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antibody Drug Conjugate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adcetris
Figure 10. Product Picture of Kadcyl
Figure 11. Product Picture of Other
Figure 12. Global Antibody Drug Conjugate Sales Market Share by Type in 2022
Figure 13. Global Antibody Drug Conjugate Revenue Market Share by Type (2018-2023)
Figure 14. Antibody Drug Conjugate Consumed in Hospital
Figure 15. Global Antibody Drug Conjugate Market: Hospital (2018-2023) & (K Units)
Figure 16. Antibody Drug Conjugate Consumed in Pharmaceutical Company
Figure 17. Global Antibody Drug Conjugate Market: Pharmaceutical Company (2018-2023) & (K Units)
Figure 18. Antibody Drug Conjugate Consumed in Research Institutions
Figure 19. Global Antibody Drug Conjugate Market: Research Institutions (2018-2023) & (K Units)
Figure 20. Global Antibody Drug Conjugate Sales Market Share by Application (2022)
Figure 21. Global Antibody Drug Conjugate Revenue Market Share by Application in 2022
Figure 22. Antibody Drug Conjugate Sales Market by Company in 2022 (K Units)
Figure 23. Global Antibody Drug Conjugate Sales Market Share by Company in 2022
Figure 24. Antibody Drug Conjugate Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Antibody Drug Conjugate Revenue Market Share by Company in 2022
Figure 26. Global Antibody Drug Conjugate Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 29. Americas Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 30. APAC Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 31. APAC Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 32. Europe Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 33. Europe Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 36. Americas Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 37. Americas Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 38. Americas Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 39. Americas Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 40. United States Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Antibody Drug Conjugate Sales Market Share by Region in 2022
Figure 45. APAC Antibody Drug Conjugate Revenue Market Share by Regions in 2022
Figure 46. APAC Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 47. APAC Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 48. China Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 56. Europe Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 57. Europe Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 58. Europe Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 59. Germany Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 68. Egypt Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Antibody Drug Conjugate in 2022
Figure 74. Manufacturing Process Analysis of Antibody Drug Conjugate
Figure 75. Industry Chain Structure of Antibody Drug Conjugate
Figure 76. Channels of Distribution
Figure 77. Global Antibody Drug Conjugate Sales Market Forecast by Region (2024-2029)
Figure 78. Global Antibody Drug Conjugate Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Antibody Drug Conjugate Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Antibody Drug Conjugate Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Antibody Drug Conjugate Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Antibody Drug Conjugate
Figure 2. Antibody Drug Conjugate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Drug Conjugate Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antibody Drug Conjugate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antibody Drug Conjugate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adcetris
Figure 10. Product Picture of Kadcyl
Figure 11. Product Picture of Other
Figure 12. Global Antibody Drug Conjugate Sales Market Share by Type in 2022
Figure 13. Global Antibody Drug Conjugate Revenue Market Share by Type (2018-2023)
Figure 14. Antibody Drug Conjugate Consumed in Hospital
Figure 15. Global Antibody Drug Conjugate Market: Hospital (2018-2023) & (K Units)
Figure 16. Antibody Drug Conjugate Consumed in Pharmaceutical Company
Figure 17. Global Antibody Drug Conjugate Market: Pharmaceutical Company (2018-2023) & (K Units)
Figure 18. Antibody Drug Conjugate Consumed in Research Institutions
Figure 19. Global Antibody Drug Conjugate Market: Research Institutions (2018-2023) & (K Units)
Figure 20. Global Antibody Drug Conjugate Sales Market Share by Application (2022)
Figure 21. Global Antibody Drug Conjugate Revenue Market Share by Application in 2022
Figure 22. Antibody Drug Conjugate Sales Market by Company in 2022 (K Units)
Figure 23. Global Antibody Drug Conjugate Sales Market Share by Company in 2022
Figure 24. Antibody Drug Conjugate Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Antibody Drug Conjugate Revenue Market Share by Company in 2022
Figure 26. Global Antibody Drug Conjugate Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 29. Americas Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 30. APAC Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 31. APAC Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 32. Europe Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 33. Europe Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Antibody Drug Conjugate Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Antibody Drug Conjugate Revenue 2018-2023 ($ Millions)
Figure 36. Americas Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 37. Americas Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 38. Americas Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 39. Americas Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 40. United States Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Antibody Drug Conjugate Sales Market Share by Region in 2022
Figure 45. APAC Antibody Drug Conjugate Revenue Market Share by Regions in 2022
Figure 46. APAC Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 47. APAC Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 48. China Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 56. Europe Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 57. Europe Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 58. Europe Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 59. Germany Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure 68. Egypt Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Antibody Drug Conjugate Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Antibody Drug Conjugate in 2022
Figure 74. Manufacturing Process Analysis of Antibody Drug Conjugate
Figure 75. Industry Chain Structure of Antibody Drug Conjugate
Figure 76. Channels of Distribution
Figure 77. Global Antibody Drug Conjugate Sales Market Forecast by Region (2024-2029)
Figure 78. Global Antibody Drug Conjugate Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Antibody Drug Conjugate Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Antibody Drug Conjugate Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Antibody Drug Conjugate Revenue Market Share Forecast by Application (2024-2029)
